|
![](images/line.gif) |
|
Home > Pharmaceuticals & Biotechnology > Biotechnology > Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
|
Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
|
![](images/tableofcontents_btn.gif) |
|
![](images/research_assistance_btn.gif) |
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
|
|
![](images/line2.gif) |
|
|
|
|
|
|
|
Local PDF: $1850.00 Other Formats: Global PDF, DataPack
|
![](images/line3.gif) |
|
|
|
|
|
|
|